Back
ESC Premium Access

Application of the 2019 ESC/EAS dyslipidemia guidelines to a Mexican population: evaluating treatment targets for secondary prevention in clinical practice

Session: Risk Factors and Prevention ePosters
Topic: Drug therapy
Speaker: Doctor C. Laguna Munoz (Aguascalientes, MX)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

0

About the speaker

Doctor Cesar Ivan Laguna Munoz

Centenary Miguel Hidalgo Hospital, Aguascalientes (Mexico)
0 follower

224 more presentations in this session

High risk characteristics in patients with hypertrophic cardiomiyopathy for predicting cardiovascular events

Speaker: Doctor B. Keskin (Istanbul, TR)

Access
Abstract
Slides
0
Thumbnail

Cardiac biomarkers as prognosticators among SARS-CoV-19 patients in a tertiary hospital in Philippines

Speaker: Doctor R. Ong (Makati, PH)

Access
Abstract
Slides
0
Thumbnail

Prevalence of atherosclerosis risk factors in Egyptian patients with acute coronary syndromes; final data of the nationwide cross-sectional CardioRisk project

Speaker: Doctor A. Bendary (Benha, EG)

Access
Abstract
Slides
0
Thumbnail

SF-12 Physical and Mental Health Scales predict cardiovascular events after hospitalization

Speaker: Mr R. Gascuena (Leganes, ES)

Access
Abstract
Slides
0
Thumbnail

Comparison of traditional versus artificial intelligence based coronary artery disease risk prediction scores in young patients with acute coronary syndrome

Speaker: Doctor S. Vohra (Lucknow, IN)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Doctor C. Laguna Munoz, Doctor B. Keskin, Doctor R. Ong, Doctor A. Bendary, Mr R. Gascuena...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

Single-Pill Combinations: From Guidelines to Practice.

30 August 2021

Open Access

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice - panel.

30 August 2021

ESC Premium Access

Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study

27 August 2021

ESC 365 is supported by

logo Novo Nordisk